Recurrent Abdominal Pain and Exocrine Pancreatic Insufficiency
A Phase II Study to Identify the Role of Exocrine Pancreatic Insufficiency in Pediatric Patients With Abdominal Pain (RAP) Who Are Undergoing Upper Endoscopy Using Synthetic Human Secretin
Sponsor: ChiRhoClin, Inc.
Terminated
Data collection discontinuity and sponsor reallocation of study resources to manufacturing
Other terminated trials from ChiRhoClin, Inc.
More terminations from ChiRhoClin, Inc.
Other Abdominal Pain trials with similar outcome
A PHASE3 clinical study on Abdominal Pain and Irritable Bowel Syndrome, this trial is terminated or withdrawn. The trial is conducted by ChiRhoClin, Inc. and has accumulated 6 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
May 2024 — Jul 2024 [monthly]
Terminated PHASE3
Status: Unknown Status → Terminated
-
Jan 2024 — May 2024 [monthly]
Unknown Status PHASE3
Status: Not Yet Recruiting → Unknown Status
-
Jan 2021 — Jan 2024 [monthly]
Not Yet Recruiting PHASE3
▶ Show 1 earlier version
-
Feb 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- ChiRhoClin, Inc.
- Orlando Health, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .